Results 21 to 30 of about 3,671 (210)

The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C‐Reactive Protein Levels

ACR Open Rheumatology, 2021
Objective Biological agents have shown markedly different response rates by baseline C‐reactive protein (CRP). Here, we determine the response of patients with nonradiographic axial spondyloarthritis (nr‐axSpA) to etanercept stratified by their baseline ...
Hoi Ki Joshua Tam, Peter Nash, Philip C. Robinson   +2 more
doaj   +1 more source

Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis

Frontiers in Medicine, 2022
BackgroundTo evaluate gender differences in disease activity and health status (HS) in patients with radiographic axial spondyloarthritis (r-axSpA)/ankylosing spondylitis (AS).MethodsAncillary analysis of the MIDAS study, an observational, non ...
Cristina Fernández-Carballido, Vega Jovaní, Emma Beltrán Catalán, Manuel José Moreno-Ramos, Jesús Sanz Sanz, Adela Gallego, M. Luz García Vivar, José Manuel Rodríguez-Heredia, Cristina Sanabra, Carlos Sastré   +9 more
doaj   +1 more source

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

Arthritis Research & Therapy, 2023
Objectives To (i) determine whether sustained disease activity states, as measured by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS), impact function, and (ii) evaluate ...
Walter P. Maksymowych, Robert D. Inman, Louis Bessette, Proton Rahman, Emmanouil Rampakakis, Odalis Asin-Milan, Meagan Rachich, Anne Marilise Marrache, Allen J. Lehman   +8 more
doaj   +1 more source

Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study

Rheumatology and Therapy, 2023
Introduction Guselkumab previously showed greater improvements versus placebo in axial symptoms in patients with psoriatic arthritis (PsA) (assessed by Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] and Ankylosing Spondylitis Disease ...
Philip J. Mease, Dafna D. Gladman, Denis Poddubnyy, Soumya D. Chakravarty, May Shawi, Alexa P. Kollmeier, Xie L. Xu, Stephen Xu, Atul Deodhar, Xenofon Baraliakos   +9 more
doaj   +1 more source

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain

BMJ Open, 2022
Objectives To determine the frequency of sustained remission (R) or low diseas activity (LDA) in patients with axial spondyloarthritis (axSpA) undergoing long-term biological therapy and to analyse predictive factors for achieving these outcomes.Design ...
Alejandro Balsa, Victoria Navarro-Compán, Laura Nuño, Karen Franco-Gómez, Diana Peiteado, Irene Monjo, Alejandro Villalba, Patricia Bogas, Diego Benavent, Marta Novella-Navarro, Chamaida Plasencia-Rodríguez, Romina Nieto   +11 more
doaj   +1 more source

An assessment in spondyloarthritis international society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS [PDF]

, 2017
Introduction In a previous phase, 12 draft definitions for clinically important worsening in axial spondyloarthritis (axSpA) were selected, of which 3 were based on absolute changes in Ankylosing Spondylitis Disease Activity Score (ASDAS)-CRP (ASDAS ...
Robert B M Landewé, Wei, J.C.C., Meghnathi, Bhowmik, Kiltz, Uta, ASAS-FLARE Study Grp, Heijde, Désirée, van Der, Wei, James Cheng Chung, Nurullah Akkoc, Gossec, Laure, Molto, Anna, Landewe, R.B.M., ATAGÜNDÜZ, MEHMET PAMİR, Anna Molto, Dougados, Maxime, Elzorkany, B.K., Laure Gossec, Landewe, Robert B. M., Désirée van der Heijde, Maxime Dougados, Molto, A., Bassel Kamal Elzorkany, Gossec, L., Akkoc, N., Landewé, Robert B M, Gu, J.R., van der Heijde, D. sirée, Kiltz, U., van der Heijde, Desiree, Akkoc, Nurullah, Atagunduz, P., Jieruo Gu, Atagunduz, Pamir, Pamir Atagunduz, Elzorkany, Bassel Kamal, Meghnathi, B., Heijde, D. van der, Gu, Jieruo, James Cheng Chung Wei, Bhowmik Meghnathi, Uta Kiltz, Dougados, M.   +40 more
core   +2 more sources

CHANGE OF ACTIVITY, FUNCTIONAL CLASS, AND SPINAL MOBILITY IN ANKYLOSING SPONDYLOSIS DURING THERAPY WITH DIFFERENT PHARMACOLOGICAL AGENTS

Научно-практическая ревматология, 2014
Objective: To assess change of disease activity and the functional status of patients with ankylosing spondylitis (AS) during treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), synthetic disease-modifying antirheumatic drugs (DMARDs), and ...
M. Ivanova, R. Stoilov, S. G. Radenska-Lopovok, I. Manolova   +3 more
doaj   +1 more source

Investigation of changes in ankylosing spondylitis disease activity through 2021 COVID-19 wave in Taiwan by using electronic medical record management system

Scientific Reports, 2023
We aim to investigate the alteration in disease activity of ankylosing spondylitis (AS) individuals before, during, and after the COVID-19 wave in Taiwan by using electronic medical-record management system (EMRMS).
Pei-Ju Huang, Yun-Wen Chen, Tsai-Hung Yen, Yen-Tze Liu, Shih-Ping Lin, Hsin-Hua Chen   +5 more
doaj   +1 more source

Ocjena aktivnosti ankilozantnog spondilitisa primjenom BASDAI i ASDAS instrumenta [PDF]

, 2011
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is the most frequently used ankylosing spondylitis activity assesment by which through 6 questions 5 basic diseases symptoms (fatigue, back pain, joint pain/swelling, enthesitic points ...
Iva Žagar, Kristina Kovač, Đurđica Babić-Naglić, Perić, Porin, Dubravka Bobek, Bobek, Dubravka, Kovač Durmiš, Kristina, Kovač, Kristina, Babić-Naglić, Đurđica, Kristina Kovač Durmiš, Porin Perić, Ćurković, Božidar, Žagar, Iva, Božidar Ćurković   +13 more
core   +1 more source

Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?

RMD Open, 2016
Objective Obesity is associated with elevated C reactive protein (CRP) levels. The Ankylosing Spondylitis Disease Activity Score (ASDAS) combines patient-reported outcomes (PROs) and CRP.
Robert Landewé, Désirée van der Heijde, Hanne Dagfinrud, Roberta Ramonda, Floris A van Gaalen, Rosaline van den Berg, Pauline A C Bakker, Zineb Ez-Zaitouni, Miranda van Lunteren, Esmeralda Molenaar, Roxana Rubio Vargas   +10 more
doaj   +1 more source